Ultimately, Dr. Minn notes, success in immuno-oncology will be measured in multiple ways: Scientifically, by the depth of ...

A short burst of immunotherapy before surgery is delivering surprisingly powerful results for a specific type of colorectal ...

For patients diagnosed with stage 4 cancer, a condition often accompanied by limited treatment options and grim prognoses, immunotherapy offers a new ray of hope. This groundbreaking approach utilizes ...

Researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, will present 49 abstracts at the 2026 American Society of ...

Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have identified a promising new strategy to overcome resistance to immunotherapy in colorectal cancer ...

In a sponsored episode of Podnosis, host Chris Hayden speaks with Dr. Steven O’Day, chief medical officer at Agenus, about the latest advancements in immunotherapy. With more than 30 years of ...

Dr. David Greenberg outlines bladder cancer staging, BCG, immunotherapy, surgery, quality of life impacts and long-term ...

Cancer treatment during the last 40 years depended on three main methods which included surgical procedures and chemotherapy ...

Kristin Surdy started working as a nurse in the chemo unit at Mayo Clinic in December 2025, only months after she started ...

Immunotherapy uses the power of your immune system to fight your cancer. One type of immunotherapy is called an immune checkpoint inhibitor. Your immune system has built-in checkpoints that help it ...

Subcutaneous immunotherapy injections work the same way as their intravenous counterparts — by changing or enhancing a person’s immune responses to cancer. Immunotherapy for cancer is a broad category ...

Groundbreaking research and clinical trials are reshaping liver cancer treatment, especially hepatocellular carcinoma (HCC), with precision medicine and immunotherapy combinations leading the way.